Showing results (241-250 of 337) with videos related to

Sort By:
Pageof 34
The American Journal of Gastroenterology|September 25, 2001
Long term survival after pancreatic resection for pancreatic adenocarcinomaN A Ahmad, J D Lewis, G G Ginsberg, et al.
The Journal of Clinical Investigation|October 1, 1991
Deficiency of skeletal muscle succinate dehydrogenase and aconitase. Pathophysiology of exercise in a novel human muscle oxidative defectR G Haller, K G Henriksson, L Jorfeldt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Phase I and pharmacokinetic trial of the novel taxane BMS-184476 administered as a 1-hour intravenous infusion in combination with cisplatin every 21 daysWeijing Sun, James P Stevenson, Maryann L Gallagher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2001
Phase I clinical and pharmacogenetic trial of irinotecan and raltitrexed administered every 21 days to patients with cancerJ P Stevenson, M Redlinger, L A Kluijtmans, et al.
The New England Journal of Medicine|October 13, 2001
A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patientsD J Sargent, R M Goldberg, S D Jacobson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data setMichael J O'Connell, Megan E Campbell, Richard M Goldberg, et al.
American Journal of Clinical Oncology|August 1, 1995
Phase II trial of etoposide, doxorubicin, and cisplatin combination in advanced measurable gastric cancer. An Eastern Cooperative Oncology Group studyJ L Clark, O Küçük, D S Neuberg, et al.
International Journal of Radiation Oncology, Biology, Physics|October 27, 1998
Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology GroupT J Smith, L M Ryan, H O Douglass, et al.
Clinical Colorectal Cancer|March 29, 2021
Benefit of Oxaliplatin in Stage III Colon Cancer According to IDEA Risk Groups: Findings from the ACCENT Database of 4934 PatientsOfer Margalit, Ben Boursi, Manel Rakez, et al.
Annals of Internal Medicine|October 22, 2003
Association of hospital procedure volume and outcomes in patients with colon cancer at high risk for recurrenceJeffrey A Meyerhardt, Paul J Catalano, Deborah Schrag, et al.
Pageof 34